Skip to content
  • Home
  • Technology
  • Products
    • Lumee Oxygen
    • Lumee Glucose
    • Data Platform
  • Clinical Evidence
  • Pipeline
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Management Team
    • Board of Directors
    • Governance Documents
    • Email Alerts
  • About
  • Contact
    • Careers Profusa
  • Regulatory
  • Home
  • Technology
  • Products
    • Lumee Oxygen
    • Lumee Glucose
    • Data Platform
  • Clinical Evidence
  • Pipeline
  • Investor Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Info
    • SEC Filings
    • Management Team
    • Board of Directors
    • Governance Documents
    • Email Alerts
  • About
  • Contact
    • Careers Profusa
  • Regulatory

Month: April 2017

Ben Hwang, CEO at Profusa, Interviewed by LLAMA Host Peter Bowes

Ben Hwang, Chairman and CEO at Profusa, spoke to LLAMA host, Peter Bowes, at TEDMED in California. LLAMA, …

Pioneering real-time biochemistry that drives AI-led, personalized healthcare technologies.

NASDAQ: PFSA

Linkedin X-twitter Youtube

Quick Links

  • About Us
  • Lumee™ Oxygen
  • Lumee™ Glucose
  • Data Platform
  • Clinical Evidence
  • Pipeline
  • Careers

Investors

  • Overview
  • News & Events
  • Stock Info
  • SEC Filings
  • Governance
  • IR Resources

Get in Touch

  • [email protected]
  • +1 (888) 650-2357
  • 626 Bancroft Way, Suite A
    Berkeley, CA, 94710
© 2026 Profusa, Inc. All rights reserved.
Financial Conflict of Interest Policy | Regulatory